Resultats de la cerca - Anton Pozniak

Refinar resultats
  1. 1
    HIV Drug Resistance — An Emerging Threat to Epidemic Control

    HIV Drug Resistance — An Emerging Threat to Epidemic Control per Chris Beyrer, Anton Pozniak

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Large disparities in HIV treatment cascades between eight European and high‐income countries – analysis of break points

    Large disparities in HIV treatment cascades between eight European and high‐income countries – analysis of break points per Alice Raymond, Andrew Hill, Anton Pozniak

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs

    Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs per Mariana S. Sousa, Anton Pozniak, Marta Boffito

    Publicat 2008
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Are new antiretroviral treatments increasing the risks of clinical obesity?

    Are new antiretroviral treatments increasing the risks of clinical obesity? per Andrew Hill, Laura Waters, Anton Pozniak

    Publicat 2019
    Obtenir text complet
    Editorial
    Afegir a favorits
    Guardat en:
  5. 5
    Has the time come to abandon efavirenz for first-line antiretroviral therapy?

    Has the time come to abandon efavirenz for first-line antiretroviral therapy? per François Raffi, Anton Pozniak, M A Wainberg

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    The treatment of tuberculosis in HIV-infected persons

    The treatment of tuberculosis in HIV-infected persons per Anton Pozniak, Robert F. Miller, Peter L. Ormerod

    Publicat 1999
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?

    Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety? per Andrew Hill, Sophie Hughes, Dzintars Gotham, Anton Pozniak

    Publicat 2018
    Editorial
    Afegir a favorits
    Guardat en:
  8. 8
    Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?

    Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety? per Andrew Hill, Sophie Hughes, Dzintars Gotham, Anton Pozniak

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Bacterial Vaginosis, Ethnicity, and the Use of Genital Cleaning Agents: A Case Control Study

    Bacterial Vaginosis, Ethnicity, and the Use of Genital Cleaning Agents: A Case Control Study per Sasikala Rajamanoharan, Nicola Low, Simon B. Jones, Anton Pozniak

    Publicat 1999
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Rapidly declining HIV infection in MSM in central London

    Rapidly declining HIV infection in MSM in central London per Nneka Nwokolo, Andrew Hill, Alan McOwan, Anton Pozniak

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Gonorrhoea in inner London: results of a cross sectional study

    Gonorrhoea in inner London: results of a cross sectional study per Nicola Low, Gavin Daker‐White, David H. Barlow, Anton Pozniak

    Publicat 1997
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Episodic Sexual Transmission of HIV Revealed by Molecular Phylodynamics

    Episodic Sexual Transmission of HIV Revealed by Molecular Phylodynamics per Fraser Lewis, G. Hughes, Andrew Rambaut, Anton Pozniak, Andrew Brown

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP

    How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP per Victoria Pilkington, Andrew Hill, Sophie Hughes, Nneka Nwokolo, Anton Pozniak

    Publicat 2018
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  14. 14
    Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology

    Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology per Julia del Amo, Adam S. Malin, Anton Pozniak, Kevin M. De Cock

    Publicat 1999
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  15. 15
    Clinical management of tuberculosis and HIV-1 co-infection

    Clinical management of tuberculosis and HIV-1 co-infection per Charlotte Schutz, Graeme Meintjes, Fahad Almajid, Robert J. Wilkinson, Anton Pozniak

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Virologic Rebound on HAART in the Context of Low Treatment Adherence Is Associated With a Low Prevalence of Antiretroviral Drug Resistance

    Virologic Rebound on HAART in the Context of Low Treatment Adherence Is Associated With a Low Prevalence of Antiretroviral Drug Resistance per John Walsh, Anton Pozniak, Mark Nelson, Sundhiya Mandalia, Brian George Gazzard

    Publicat 2002
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Clinical Characteristics of Iris Syndrome in Patients with HIV and Tuberculosis

    Clinical Characteristics of Iris Syndrome in Patients with HIV and Tuberculosis per Christos Michailidis, Anton Pozniak, Sundhiya Mandalia, Sheena Basnayake, Mark Nelson, Brian Gazzard

    Publicat 2005
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades

    Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades per Jacob Levi, Alice Raymond, Anton Pozniak, Pietro Vernazza, Philipp Köhler, Andrew Hill

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Comparative Safety and Neuropsychiatric Adverse Events Associated With Efavirenz Use in First-Line Antiretroviral Therapy

    Comparative Safety and Neuropsychiatric Adverse Events Associated With Efavirenz Use in First-Line Antiretroviral Therapy per Nathan Ford, Zara Shubber, Anton Pozniak, Marco Vitória, Meg Doherty, Catherine Kirby, Alexandra Calmy

    Publicat 2015
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  20. 20
    Loss of blood CD11c+ myeloid and CD11c−plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load

    Loss of blood CD11c+ myeloid and CD11c−plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load per Heather Donaghy, Anton Pozniak, Brian Gazzard, Nad A. Qazi, Jill Gilmour, Frances Gotch, Steven Patterson

    Publicat 2001
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: